Sinphar Pharmaceutical Co., Ltd.

8 patents currently held · Updated Nov 15, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

Ending by 2030

Aug 2031

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due May 26, 2027
The maintenance fee for Anti-Fatigue Composition Used for Increasing Endurance Performance, and Use of the Same (US 10,485,836) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Patent	Title	Status	Expires	Confidence
US 9,757,392	Pharmaceutical composition and extract of Poria for enhancing uptake of nutrients In force Term ends Aug 10, 2031 · From the USPTO record	In force	Term ends Aug 10, 2031	From the USPTO record
US 9,339,522	Method for Regulating Blood Glucose Level In force Term ends Jul 18, 2034 · High confidence	In force	Term ends Jul 18, 2034	High confidence
US 9,993,509	Method for Regulating Blood Glucose Level In force Term ends Oct 24, 2034 · High confidence	In force	Term ends Oct 24, 2034	High confidence
US 9,370,540	K2 Composition and the Preparation Method and Use of the Same In force Term ends May 20, 2035 · High confidence	In force	Term ends May 20, 2035	High confidence
US 10,973,863	Method for Regulating, Preventing And/Or Treating Pulmonary Injury In force Term ends May 20, 2035 · High confidence	In force	Term ends May 20, 2035	High confidence
US 10,967,029	Method of using Cistanche tubulosa extract to prevent, slow down, or treat an eye disease caused by oxidative stress In force Term ends Apr 18, 2036 · From the USPTO record	In force	Term ends Apr 18, 2036	From the USPTO record
US 11,654,169	Methods for Protecting Skin And/Or Promoting Wound Healing In force Term ends Sep 5, 2037 · High confidence	In force	Term ends Sep 5, 2037	High confidence
US 10,485,836	Anti-Fatigue Composition Used for Increasing Endurance Performance, and Use of the Same In force Term ends Feb 13, 2038 · High confidence	In force	Term ends Feb 13, 2038	High confidence

Also on record, not counted in the 8: 2 lapsed for an unpaid fee · 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 abandoned · 8 no status recorded

List them